HPLC-MS/MS determination of a hardly soluble drug in human urine through drug-albumin binding assisted dissolution
Related Experiment Video
Updated: Jul 2, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Ramona Rodila1, Grace E Kim, Leimin Fan
1Department of Drug Analysis, Abbott Laboratories, Abbott Park, IL 60064, USA.
Abstract:
ABT-263 is under development for treatment of cancer. In order to support clinical trials, an analytical method for ABT-263 quantification in human urine became necessary. Due to the extremely poor solubility of ABT-263 in aqueous and most common organic solvents, a critical step was to dissolve the drug into urine matrix. Although other potential approaches could be used, addition of powder albumin was found to be the most advantageous. Albumin powder does not significantly alter urine sample volume (< or = 2.8%) and a range of albumin to urine sample volume ratios can be allowed for full recovery of drug and thus accurate quantification. The procedure is fairly simple and can potentially be a universal approach for compounds with low solubility in urine, but strong protein binding. The method has been validated to support clinical trials.
Related Concept Videos
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Drug Dissolution: Requirements and Profile Comparison
Factors Influencing Drug Absorption: Drug Dissolution
Drug Distribution: Plasma Protein Binding
In Vitro Drug Dissolution: Alternative Methods
Measurement of Bioavailability: Pharmacokinetic Methods
